John Hayball News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SA researcher hopes locally developed jab will protect against other COVID strains 18/05/2021|8min A leading South Australian immunologist has been awarded $3 million from the federal government to accelerate the development of a local COVID-19 vaccine. Professor John Hayball told Sky News they already had a “good first line vaccine candidate” which was similar to other vaccines already developed. “The nature of the technology means we can put a lot more genetic material into the vector itself, so that means we could put additional viral proteins from the SARs virus in so we’re not ...

Australians urged not to question COVID vaccine 18/05/2021|5min A leading South Australian immunologist has urged Australians not to ask questions about the COVID-19 vaccine and just simply take the jab when it is offered to them. “We’re in the privileged position that we can be hesitant, we’ve done so well in coping with COVID the last 12, 14 months,” Professor John Hayball told Sky News. “But I would encourage everybody out there offered a vaccine, don’t ask any questions really, please take it.” Favourite

South Australia accelerates COVID-19 vaccine development The UniSA-Sementis vaccine aims to target mutant variants. Credit: Chalffy / Getty Images. A South Australian immunologist has been awarded $3 million from the Federal Government to accelerate the development of a next-generation COVID-19 vaccine, which may become a second line of defence against the virus. The grant is for a vaccine based on the Sementis Copenhagen Vector (SCV) platform, which will target mutant strains. It can either be received as a stand-alone vaccine or as a booster to complement current vaccines . John Hayball, re...

Credit: University of South Australia A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what's anticipated to be the second line of defence against the virus. Professor John Hayball is a researcher at the University of South Australia and Chief Scientific Officer at Adelaide biotechnology company Sementis. UniSA and Sementis have partnered in the development of a next-generation Covid-19 vaccine based on the Sementis Copenhagen Vector (SCV) platform. The vaccine has been in development...

South Australian immunologist receives $3 million to accelerate work on Covid-19 vaccine A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what's anticipated to be the second line of defence against the virus. Professor John Hayball is a researcher at the University of South Australia and Chief Scientific Officer at Adelaide biotechnology company Sementis. UniSA and Sementis have partnered in the development of a next-generation Covid-19 vaccine based on the Sementis Copenhagen Vector ...